Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a

Z. Tomášová, P. Hluštík, M. Král, P. Otruba, R. Herzig, A. Krobot, P. Kaňovský,

. 2013 ; 23 (3) : 337-44. [pub] 20111230

Language English Country United States

Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND AND PURPOSE: Botulinum toxin (BoNT) treatment relieves focal arm spasticity after stroke, likely acting at several hierarchical levels of the motor system. The central correlate of BoNT-induced spasticity relief may be detected using repeated functional MRI (fMRI) during motor task. METHODS: Five patients (4 males, 1 female, mean age 67 years) with hemiparesis and distal arm spasticity after chronic ischemic stroke were studied. FMRI was performed while moving the paretic hand in three sessions: before and 4 and 11 weeks after BoNT treatment. RESULTS: Arm spasticity significantly decreased following BoNT treatment across the group (mean modified Ashworth scale change .6). FMRI prior to BoNT treatment showed extensive bilateral active networks, whereas post-BoNT activation was limited to midline and contralateral sensorimotor cortices, and the third examination, when the toxin effect has worn off, again showed extensive activation similar to pre-BoNT examination. Post-BoNT session 2 compared to sessions 1 and 3 demonstrated a significantly less activation in contralateral frontoparietal areas including inferior frontal, postcentral, and middle frontal gyri as well as transient crossed cerebellar activation. CONCLUSION: Relief of post-stroke arm spasticity may be associated with changes at several hierarchical levels of the cortical sensorimotor system, including the prefrontal cortex.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15032123
003      
CZ-PrNML
005      
20151013122811.0
007      
ta
008      
151005s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/j.1552-6569.2011.00682.x $2 doi
035    __
$a (PubMed)22212022
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tomášová, Zuzana $u Department of Neurology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic.
245    10
$a Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a / $c Z. Tomášová, P. Hluštík, M. Král, P. Otruba, R. Herzig, A. Krobot, P. Kaňovský,
520    9_
$a BACKGROUND AND PURPOSE: Botulinum toxin (BoNT) treatment relieves focal arm spasticity after stroke, likely acting at several hierarchical levels of the motor system. The central correlate of BoNT-induced spasticity relief may be detected using repeated functional MRI (fMRI) during motor task. METHODS: Five patients (4 males, 1 female, mean age 67 years) with hemiparesis and distal arm spasticity after chronic ischemic stroke were studied. FMRI was performed while moving the paretic hand in three sessions: before and 4 and 11 weeks after BoNT treatment. RESULTS: Arm spasticity significantly decreased following BoNT treatment across the group (mean modified Ashworth scale change .6). FMRI prior to BoNT treatment showed extensive bilateral active networks, whereas post-BoNT activation was limited to midline and contralateral sensorimotor cortices, and the third examination, when the toxin effect has worn off, again showed extensive activation similar to pre-BoNT examination. Post-BoNT session 2 compared to sessions 1 and 3 demonstrated a significantly less activation in contralateral frontoparietal areas including inferior frontal, postcentral, and middle frontal gyri as well as transient crossed cerebellar activation. CONCLUSION: Relief of post-stroke arm spasticity may be associated with changes at several hierarchical levels of the cortical sensorimotor system, including the prefrontal cortex.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a paže $7 D001132
650    _2
$a botulotoxiny typu A $x terapeutické užití $7 D019274
650    12
$a evokované potenciály $7 D005071
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pohyb $7 D009068
650    _2
$a svalová spasticita $x farmakoterapie $x etiologie $x patofyziologie $7 D009128
650    _2
$a nervosvalové látky $x terapeutické užití $7 D009465
650    _2
$a senzorimotorický kortex $x účinky léků $x patofyziologie $7 D066191
650    _2
$a cévní mozková příhoda $x komplikace $x farmakoterapie $x patofyziologie $7 D020521
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hluštík, Petr
700    1_
$a Král, Michal
700    1_
$a Otruba, Pavel
700    1_
$a Herzig, Roman
700    1_
$a Krobot, Alois
700    1_
$a Kaňovský, Petr
773    0_
$w MED00002833 $t Journal of neuroimaging official journal of the American Society of Neuroimaging $x 1552-6569 $g Roč. 23, č. 3 (2013), s. 337-44
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22212022 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151013123000 $b ABA008
999    __
$a ok $b bmc $g 1092999 $s 915249
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 23 $c 3 $d 337-44 $e 20111230 $i 1552-6569 $m Journal of neuroimaging $n J Neuroimaging $x MED00002833
LZP    __
$a Pubmed-20151005

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...